Source: International Congress 2019 – Clinical implications of asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gerday (Liege, Belgium), F. Schleich (Liege, Belgium), M. Henket (Liege, Belgium), F. Guissard (Liege, Belgium), V. Paulus (Liege, Belgium), R. Louis (Liege, Belgium). Characterisation of a cohort of asthmatics with severe concordant eosinophilic disease according to their IgE status. 5028

Member's Comments

No comment yet.

Related content which might interest you: Transcriptomic profiles of eosinophilic asthmatic patients classified according to their atopic status Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Clinical profile of patients with adult-onset eosinophilic asthma Source: ERJ Open Res 2016: 00100-2015 Year: 2016 Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017 Year: 2017 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Efficacy of Omalizumab in adult and pediatric severe allergic asthma according to presence of multiple allergic comorbidities: evidence from the STELLAIR study. Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Specific features of phenotypes of polymorphic haptoglobin system in patients with chronic bronchitis and healthy smokers Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Predictors of methacholine responsiveness in a population of patients with suspected bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 295s Year: 2003 Markers of eosinophilic inflammation are associated with response to the DP2 antagonist GB001 in patients with mild atopic asthma Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 The effects of IL12B promoter polymorphism on co-existence of allergic rhinitis or familial asthma history, serum total IgE and eosinophil level in asthma patients Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Incidence of allergic asthma in patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 232s Year: 2006 Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021